Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
AbbVie
Kathleen N Moore; Antoine Angelergues; Gottfried E Konecny; Yolanda García; Susana Banerjee; Domenica Lorusso; Jung-Yun Lee; John W Moroney; Nicoletta Colombo; Andrzej Roszak; Jacqueline Tromp; Tashanna Myers; Jeong-Won Lee; Mario Beiner; Casey M Cosgrove; David Cibula; Lainie P Martin; Renaud Sabatier; Joseph Buscema; Purificación Estévez-García; Lan Coffman; Shibani Nicum; Linda R Duska; Sandro Pignata; Fernando Gálvez; Yuemei Wang; Michael Method; Anna Berkenblit; Diana Bello Roufai; Toon Van Gorp; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups